Publisher
Springer Science and Business Media LLC
Subject
Nephrology,Pediatrics, Perinatology and Child Health
Reference57 articles.
1. Boumil MM, Curfman GD (2013) On access and accountability—two Supreme Court rulings on generic drugs. N Engl J Med 369:696–697
2. Hemphill CS, Sampat BN (2012) Evergreening, patent challenges, and effective market life in pharmaceuticals. J Health Econ 31:327–339
3. Debnath B, Al-Mawsawi LQ, Neamati N (2010) Are we living in the end of the blockbuster drug era? Drug News Perspect 23:670–684
4. http://www.prnewswire.com/news-releases/mylan-applauds-study-highlighting-1-trillion-in-savings-for-us-health-care-system-due-to-generic-drugs-over-past-decade-164758956.html - Press Release from Aug 2, 2012. Accessed 14-Jun-2017
5. Jacobo-Cabral CO, Garcia-Roca P, Reyes H, Lozada-Rojas L, Cruz-Antonio L, Medeiros M, Castaneda-Hernandez G (2014) Limustin(R), a non-innovator tacrolimus formulation, yields reduced drug exposure in pediatric renal transplant recipients. Pediatr Transplant 18:706–713
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献